Eric Chatelain

6PUBLICATIONS
51CO-AUTHORS
Predictive and prognostic markersMajor global burdens of diseaseChemotherapyBiomolecular modelling and designMolecular medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Aug 19, 2026
A serological method's ability to distinguish treatment regimens by assessing early antibody decline in Chagas patients: insights from E1224 data.

|Dec 03, 2024
Early assessment of antibodies decline in Chagas patients following treatment using a serological multiplex immunoassay.

Ursula Saade, Jasper de Boer, Ivan Scandale

|Dec 13, 2023
Short-course combination treatment for experimental chronic Chagas disease.

Silvia González, Richard J Wall, John Thomas

|Dec 13, 2023
DNDI-6174 is a preclinical candidate for visceral leishmaniasis that targets the cytochrome bc1.

Stéphanie Braillard, Martine Keenan, Karen J Breese

|Jul 03, 2023
Combinatorial Regimens Augment Drug Monotherapy for SARS-CoV-2 Clearance in Mice.

Irfan Ullah, Fanny Escudie, Ivan Scandale

|May 22, 2019
Drug Discovery for Chagas Disease: Impact of Different Host Cell Lines on Assay Performance and Hit Compound Selection.

Caio Haddad Franco, Laura Maria Alcântara, Eric Chatelain

Pageof 1

Frequent Collaborators

2 joint publications

Fabio Zuccotto

2 joint publications

Maan Zrein

2 joint publications

Jonathan J Lyon

2 joint publications

Silvia González